BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 14684318)

  • 1. The difluoromethylene group as a replacement for the labile oxygen in steroid sulfates: a new approach to steroid sulfatase inhibitors.
    Lapierre J; Ahmed V; Chen MJ; Ispahany M; Guillemette JG; Taylor SD
    Bioorg Med Chem Lett; 2004 Jan; 14(1):151-5. PubMed ID: 14684318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen O-sulfamates and their analogues: Clinical steroid sulfatase inhibitors with broad potential.
    Thomas MP; Potter BV
    J Steroid Biochem Mol Biol; 2015 Sep; 153():160-9. PubMed ID: 25843211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Boronic acids as inhibitors of steroid sulfatase.
    Ahmed V; Liu Y; Silvestro C; Taylor SD
    Bioorg Med Chem; 2006 Dec; 14(24):8564-73. PubMed ID: 16973364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and evaluation of analogues of estrone-3-O-sulfamate as potent steroid sulfatase inhibitors.
    Lawrence Woo LW; Leblond B; Purohit A; Potter BV
    Bioorg Med Chem; 2012 Apr; 20(8):2506-19. PubMed ID: 22455789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of zebrafish steroid sulfatase and comparative analysis of the enzymatic properties with human steroid sulfatase.
    Kurogi K; Yoshihama M; Williams FE; Kenmochi N; Sakakibara Y; Suiko M; Liu MC
    J Steroid Biochem Mol Biol; 2019 Jan; 185():110-117. PubMed ID: 30118815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of steroid sulfatase with 4-substituted estrone and estradiol derivatives.
    Phan CM; Liu Y; Kim BM; Mostafa Y; Taylor SD
    Bioorg Med Chem; 2011 Oct; 19(20):5999-6005. PubMed ID: 21925885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of steroid sulfatase inhibitors.
    Woo LW; Purohit A; Potter BV
    Mol Cell Endocrinol; 2011 Jul; 340(2):175-85. PubMed ID: 21238537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and structure-activity relationships of 2- and/or 4-halogenated 13β- and 13α-estrone derivatives as enzyme inhibitors of estrogen biosynthesis.
    Bacsa I; Herman BE; Jójárt R; Herman KS; Wölfling J; Schneider G; Varga M; Tömböly C; Rižner TL; Szécsi M; Mernyák E
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1271-1282. PubMed ID: 30230387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of estrone sulfate-induced uterine growth by potent nonestrogenic steroidal inhibitors of steroid sulfatase.
    Ciobanu LC; Luu-The V; Martel C; Labrie F; Poirier D
    Cancer Res; 2003 Oct; 63(19):6442-6. PubMed ID: 14559834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity relationships of 17alpha-derivatives of estradiol as inhibitors of steroid sulfatase.
    Boivin RP; Luu-The V; Lachance R; Labrie F; Poirier D
    J Med Chem; 2000 Nov; 43(23):4465-78. PubMed ID: 11087571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steroid sulfatase: molecular biology, regulation, and inhibition.
    Reed MJ; Purohit A; Woo LW; Newman SP; Potter BV
    Endocr Rev; 2005 Apr; 26(2):171-202. PubMed ID: 15561802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of novel steroid sulfatase inhibitors. I. Synthesis and biological evaluation of biphenyl-4-O-sulfamates.
    Okada M; Nakagawa T; Iwashita S; Takegawa S; Fujii T; Koizumi N
    J Steroid Biochem Mol Biol; 2003 Nov; 87(2-3):141-8. PubMed ID: 14672734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of steroid sulfatase activity and cell proliferation in ZR-75-1 and BT-474 human breast cancer cells by KW-2581 in vitro and in vivo.
    Ishida H; Nakata T; Sato N; Li PK; Kuwabara T; Akinaga S
    Breast Cancer Res Treat; 2007 Aug; 104(2):211-9. PubMed ID: 17061037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical synthesis and evaluation of 17α-alkylated derivatives of estradiol as inhibitors of steroid sulfatase.
    Fournier D; Poirier D
    Eur J Med Chem; 2011 Sep; 46(9):4227-37. PubMed ID: 21782294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel steroidal selective steroid sulfatase inhibitor KW-2581 inhibits sulfated-estrogen dependent growth of breast cancer cells in vitro and in animal models.
    Ishida H; Nakata T; Suzuki M; Shiotsu Y; Tanaka H; Sato N; Terasaki Y; Takebayashi M; Anazawa H; Murakata C; Li PK; Kuwabara T; Akinaga S
    Breast Cancer Res Treat; 2007 Dec; 106(2):215-27. PubMed ID: 17268815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D-ring modified estrone derivatives as novel potent inhibitors of steroid sulfatase.
    Fischer DS; Woo LW; Mahon MF; Purohit A; Reed MJ; Potter BV
    Bioorg Med Chem; 2003 Apr; 11(8):1685-700. PubMed ID: 12659755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steroid sulfatase mediated growth Sof human MG-63 pre-osteoblastic cells.
    Dias NJ; Selcer KW
    Steroids; 2014 Oct; 88():77-82. PubMed ID: 25042472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel p-carborane-containing multitarget anticancer agents inspired by the metabolism of 17β-estradiol.
    Kaise A; Ohta K; Endo Y
    Bioorg Med Chem; 2017 Dec; 25(24):6371-6378. PubMed ID: 29054710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrone formate: a novel type of irreversible inhibitor of human steroid sulfatase.
    Schreiner EP; Billich A
    Bioorg Med Chem Lett; 2004 Oct; 14(19):4999-5002. PubMed ID: 15341968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Steroid sulfatase inhibitor].
    Nakata T; Ishida H; Shiotsu Y
    Nihon Rinsho; 2010 Jun; 68(6):1073-8. PubMed ID: 20535958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.